IL13RA2 and neoplasm: CAR T cells were cocultured with tumor targets PBT030-2, U251T, and HT1080-IL13Rα2 at a 1:10 E:T ratio for 2 days, and viable remaining tumor cells were counted by flow cytometry, with results expressed as the percentage normalized to the tumor cell count after incubation with mock T cells.